
Commentary|Podcasts|July 14, 2023
Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
Advertisement
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
2
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
3
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
4
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
5





















































































































